At a glance
- Originator Merck & Co
- Class Antihyperglycaemics
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 07 Jun 2001 Profile reviewed but no significant changes made
- 17 Apr 1997 No-Development-Reported for Type-2 diabetes mellitus in USA (Unknown route)
- 21 Feb 1995 Preclinical development for Type-2 diabetes mellitus in USA (Unknown route)